Page last updated: 2024-10-18

glycine and Erythromelalgia

glycine has been researched along with Erythromelalgia in 1 studies

Erythromelalgia: A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"Treatment with mexiletine reduced the number and severity of pain episodes."5.35Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. ( Choi, JS; Dib-Hajj, SD; Han, C; Lin, Z; Tyrrell, L; Wang, X; Waxman, SG; Yang, Y; Zhang, L, 2009)
"Treatment with mexiletine reduced the number and severity of pain episodes."1.35Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. ( Choi, JS; Dib-Hajj, SD; Han, C; Lin, Z; Tyrrell, L; Wang, X; Waxman, SG; Yang, Y; Zhang, L, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JS1
Zhang, L1
Dib-Hajj, SD1
Han, C1
Tyrrell, L1
Lin, Z1
Wang, X1
Yang, Y1
Waxman, SG1

Other Studies

1 other study available for glycine and Erythromelalgia

ArticleYear
Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
    Experimental neurology, 2009, Volume: 216, Issue:2

    Topics: Anti-Arrhythmia Agents; Biophysics; Cell Line, Transformed; Child; Chromosomes, Human, Pair 15; Dose

2009